Cargando…
Identification of Hub Diagnostic Biomarkers and Candidate Therapeutic Drugs in Heart Failure
PURPOSE: The objective of this study was to identify the potential regulatory mechanisms, diagnostic biomarkers, and therapeutic drugs for heart failure (HF). METHODS: Differentially expressed genes (DEGs) between HF and non-failing donors were screened from the GSE57345, GSE5406, and GSE3586 datase...
Autores principales: | Guo, Yang, Ning, Bobin, Zhang, Qunhui, Ma, Jing, Zhao, Linlin, Lu, QiQin, Zhang, Dejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765546/ https://www.ncbi.nlm.nih.gov/pubmed/35058712 http://dx.doi.org/10.2147/IJGM.S349235 |
Ejemplares similares
-
Identification of hub biomarkers of myocardial infarction by single-cell sequencing, bioinformatics, and machine learning
por: Zhang, Qunhui, et al.
Publicado: (2022) -
Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis
por: Kolur, Vijayakrishna, et al.
Publicado: (2021) -
Candidate stress biomarkers for queen failure diagnostics
por: McAfee, Alison, et al.
Publicado: (2020) -
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
por: Cheng, Yang, et al.
Publicado: (2019) -
Identification of hub genes and construction of diagnostic nomogram model in schizophrenia
por: Zhang, Chi, et al.
Publicado: (2022)